We can't find the internet
Attempting to reconnect
10901.1;4 PFLS-LS
Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events
Zusammenfassung
Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events
Weitere Texte
Abstract
Development of a clinically superior alternative to today's available coronary artery stents: Qvanteq's Qstent is based on a surface modification of 'bare metal stents' and is expected to accelerate in-growth, which is generally believed to minimize the early and also late adverse cardiac events (i.e. heart attacks) that are associated with today's available 'bare metal stents' as well as 'drug-eluting stents'.
Beteiligte
Georg Noll
Kontaktperson
georg.noll@usz.ch
Universitätsspital Zürich Georg Noll Rämistrasse 100 Klinik für Kardiologie 8091 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2010-07-31
- Enddatum
- 2012-07-18
- Bewilligte Gesamtkosten
- CHF 276135.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- P004 Biochemistry, Metabolism 100.0%